{"id":"https://openalex.org/W2189603868","doi":null,"title":"A pilot study for a pivotal bioequivalence trial using two paroxetine 40 mg tablet formulations in healthy Chinese subjects","display_name":"A pilot study for a pivotal bioequivalence trial using two paroxetine 40 mg tablet formulations in healthy Chinese subjects","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2189603868","mag":"2189603868"},"language":"en","primary_location":{"id":"mag:2189603868","doi":null,"is_oa":false,"landing_page_url":"http://www.frontagelab.com/Userfiles/A-Pilot-Study-for-a-pivotal-bioequivalence-trial-using-two-paroxetine-40-mg-table-formulations.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shengjun Zhang","orcid":"https://orcid.org/0000-0002-4001-7232","observed_orcids":["https://orcid.org/0000-0002-4001-7232"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shengjun Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4001-7232","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102027216","display_name":"Quancheng Kan","orcid":"https://orcid.org/0000-0001-8848-895X","observed_orcids":["https://orcid.org/0000-0001-8848-895X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Quancheng Kan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100641777","display_name":"Jianguo Wen","orcid":"https://orcid.org/0000-0003-0952-118X","observed_orcids":["https://orcid.org/0000-0003-0952-118X","https://orcid.org/0000-0002-1574-6812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianguo Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jie Zhao","orcid":"https://orcid.org/0000-0002-0108-2189","observed_orcids":["https://orcid.org/0000-0002-0108-2189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0108-2189","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yuqiao Sheng","orcid":"https://orcid.org/0000-0002-7528-7187","observed_orcids":["https://orcid.org/0000-0002-7528-7187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuqiao Sheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7528-7187","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yidong Li","orcid":"https://orcid.org/0000-0003-2965-6196","observed_orcids":["https://orcid.org/0000-0003-2965-6196"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yidong Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2965-6196","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001038869","display_name":"Suke Sun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suke Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Feng Zhang","orcid":"https://orcid.org/0000-0003-4556-8276","observed_orcids":["https://orcid.org/0000-0003-4556-8276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4556-8276","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yang Li","orcid":"https://orcid.org/0000-0002-9544-5840","observed_orcids":["https://orcid.org/0000-0002-9544-5840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9544-5840","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Wenzhe Lv","orcid":"https://orcid.org/0000-0002-3814-4216","observed_orcids":["https://orcid.org/0000-0002-3814-4216"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenzhe Lv","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3814-4216","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013545165","display_name":"Kun Qian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kun Qian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031336321","display_name":"Zhongping John Lin","orcid":"https://orcid.org/0000-0002-3018-7131","observed_orcids":["https://orcid.org/0000-0002-3018-7131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhongping Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.21377006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.6128000020980835,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.6128000020980835,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.12449999898672104,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.1006999984383583,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.7120000123977661},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pilot-study","display_name":"pilot study","score":0.460999995470047},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.4880000054836273},{"id":"https://openalex.org/keywords/lc-ms-ms-method-validation","display_name":"LC-MS/MS method validation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/healthy-chinese-volunteers","display_name":"Chinese healthy volunteers","score":0.7580000162124634},{"id":"https://openalex.org/keywords/sample-size-calculation","display_name":"sample size determination","score":0.5239999890327454},{"id":"https://openalex.org/keywords/plasma-drug-quantitation","display_name":"plasma drug quantification","score":0.5550000071525574},{"id":"https://openalex.org/keywords/regulatory-approval-of-generic-drugs","display_name":"regulatory approval of generic drugs","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.9483219385147095},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.728158712387085},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6887952089309692},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6712016463279724},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6586968898773193},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6421844363212585},{"id":"https://openalex.org/C2994577977","wikidata":"https://www.wikidata.org/wiki/Q1203526","display_name":"Pilot trial","level":3,"score":0.6271563172340393},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.5216977000236511},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4493739902973175},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4329306483268738},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4051409661769867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35445231199264526},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.09670054912567139},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.061393171548843384},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189603868","doi":null,"is_oa":false,"landing_page_url":"http://www.frontagelab.com/Userfiles/A-Pilot-Study-for-a-pivotal-bioequivalence-trial-using-two-paroxetine-40-mg-table-formulations.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W181033957","https://openalex.org/W1503668654","https://openalex.org/W2071881631","https://openalex.org/W2087228724","https://openalex.org/W2092977693","https://openalex.org/W2099125145","https://openalex.org/W2137296158","https://openalex.org/W2137637743","https://openalex.org/W2143342727","https://openalex.org/W2154166294","https://openalex.org/W2338816059"],"related_works":["https://openalex.org/W2043032028","https://openalex.org/W2543335580","https://openalex.org/W2385465649","https://openalex.org/W2350916107","https://openalex.org/W2355854818","https://openalex.org/W2318412141","https://openalex.org/W1994747051","https://openalex.org/W3110248256","https://openalex.org/W4403466691","https://openalex.org/W2063153456"],"abstract_inverted_index":{"The":[0,75],"purpose":[1],"of":[2,21,30,71,168,315],"this":[3],"study":[4,10,54,83,107,220,250,288],"was":[5,90,143,157,276,282],"to":[6,13,51,285],"conduct":[7],"a":[8,22,85,105,286],"pilot":[9,46,98,126,175,201,231,299],"in":[11,36,53,100,123,150,289,310],"order":[12],"ob-":[14],"tain":[15],"reliable":[16],"results":[17,294],"for":[18,104,147,165,173,180,190,200,206,218,229,236,247,257],"further":[19],"planning":[20],"well-designed":[23],"pivotal":[24,43,106,128,181,191,208,219,238,249,301],"trial":[25,47,99,182,192,209,239],"comparing":[26],"the":[27,42,45,57,72,96,125,166,174,207,230,237,248,258,265,279,298,304],"bioequivalence":[28],"(BE)":[29],"two":[31,73,155,305],"paroxetine":[32,149,306],"tab-":[33],"let":[34],"formulations":[35,307],"healthy":[37,102,290],"Chinese":[38,291],"subjects.":[39],"Before":[40],"conducting":[41],"trial,":[44,176],"enrolled":[48],"14":[49],"subjects":[50],"help":[52],"design,":[55],"establishing":[56],"recruitment":[58],"period,":[59],"determining":[60,148],"pharmacokinetics":[61],"(PK)":[62],"time":[63,120],"points":[64,121],"and":[65,68,110,127,132,145,186,214,224,243,260,273,293,300,313],"sample":[66,118],"size,":[67],"assessing":[69],"BE":[70,153],"formulations.":[74],"single-center,":[76],"randomized,":[77],"open-label,":[78],"single-dose,":[79],"two-":[80],"period":[81],"crossover":[82],"with":[84],"7-day":[86],"wash-":[87],"out":[88],"interval":[89,269],"conducted":[91],"after":[92],"obtaining":[93],"information":[94],"from":[95,296],"fasted":[97,111,184,212,241],"72":[101],"volunteers":[103],"under":[108,183,193,221,240,251],"fed":[109,194,222,252],"conditions,":[112],"respectively.":[113,254],"There":[114],"were":[115],"19":[116],"PK":[117,287],"collection":[119],"employed":[122],"both":[124,297],"trials.":[129],"A":[130],"sensitive":[131],"specific":[133],"liquid":[134],"chromatog":[135],"-":[136,171,178,188,198,204,216,227,234,245,267],"raphy-tandem":[137],"mass":[138],"spectrometry":[139],"(LC-MS/":[140],"MS)":[141],"method":[142,281],"developed":[144],"validated":[146],"human":[151],"plasma.":[152],"between":[154],"articles":[156],"determined":[158],"by":[159,271],"calculating":[160],"90%":[161],"confidence":[162],"intervals":[163],"(CIs)":[164],"ratio":[167],"Cmax":[169],"91.38":[170],"110.39%":[172],"99.81":[177],"114.08%":[179],"condition,":[185,195,213,223,253],"94.06":[187],"110.41%":[189],"AUC(0-t)":[196],"96.06":[197],"110.52%":[199],"study,":[202,232],"100.88":[203],"113.05%":[205],"un-":[210],"der":[211],"97.08":[215],"106.06%":[217],"AUC(0-\u221e)":[225],"96.17":[226],"110.42%":[228],"100.85":[233],"112.81%":[235],"condition":[242],"97.22":[244],"106.14%":[246],"These":[255],"values":[256],"test":[259],"reference":[261],"products":[262],"are":[263,308],"within":[264],"80":[266],"125%":[268],"proposed":[270,280],"FDA":[272],"EMEA.":[274],"It":[275],"concluded":[277],"that":[278,303],"successfully":[283],"applied":[284],"volunteers,":[292],"showed":[295],"studies":[302],"bioequivalent":[309],"their":[311],"rates":[312],"extent":[314],"absorption.":[316]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}